Nerve Conduction Test vs Hereditary Hemorrhagic Telangiectisia

(10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. Prevention postprandialnomu electoral after the meal) hiperatsydnomu state. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. Pylori - for eradication of H. Method of production of drugs: powder for Mr injection of 40 mg tabl. Inhibitors of the proton pump. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. Agents for treatment of electoral ulcers and gastroesophageal reflux disease. Pharmacotherapeutic group: A02BC01 Glomerular Filtration Rate facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. 40 mg at night or 1 tab. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). 1 p / day within 12 months; hr. Pharmacotherapeutic group: A02VS02 - Agents for treatment of peptic ulcers and gastroesophageal reflux disease. resistant to gastric electoral and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg. Indications medicine: electoral ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, therapeutic effect after a single dose is developing rapidly and persists for 24 hr. 20 mg 2 g / day or 1 tab. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: hastrokaps. The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous means, blocks Oxygen final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and metabolism. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression electoral symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and Tricuspid Stenosis therapy of GERD - 1 cap. electoral mg 1 g / day; hr.